Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.
Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.
Health scores for Supriyalifescience covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (74), financial health (95), director (45) and company-foundation signals.
- Operating for 18+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2025 - slightly behind.
- Profitable in FY 2026.
- Positive net worth.
- 13 directors on the board.
- Director KRISHNA RAGHUNATHAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Supriyalifescience Company identity, industry, contact, and registration details from MCA and company records.
Supriyalifescience is a listed public limited company, first registered with ROC Mumbai I on 26 March 2008. The registered office is at 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai, Maharashtra.
In its MCA filings the main business is listed as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 98.17% of turnover.
It has 13 directors: Smita Satish Wagh, Kothandaraman Hari, Neelam Yashpal Arora and 10 others. The longest-serving is Smita Satish Wagh, on the board since 2008; the most recent to join is Manish Ishwarlal Panchal, appointed in February 2026. Shivani Satish Wagh is the managing director. 15 former directors are on record; the most recent to leave was Rajeev Kumar Jain in June 2024.
₹16.1 crore of its ₹35 crore authorised capital is paid up (about 46%). Its latest balance sheet on MCA is for the year ending 31 March 2025, and the last AGM was on 24 September 2025. Six charges (secured loans) are still open, with Axis Bank Limited among the lenders, and 39 more have been paid off. Its shares trade on BSE (543434) and NSE (SUPRIYA).
- Location 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East),, Mumbai, Maharashtra - 400063
- Website supriyalifescience.com
Current Directors of Supriyalifescience (13) Current board members from MCA filings, including designation and appointment details.
Financial Performance of Supriyalifescience Bands and Low / Medium / High trend shape. Exact figures unlock with your report.
Charges of Supriyalifescience Open and satisfied charges registered against the company with MCA.
| Lender | Amount | Status |
|---|---|---|
|
Idbi Trusteeship Services Limited
Creation Date: 26 Jun 2025 |
114.00 cr | Closed |
|
Axis Bank Limited
Creation Date: 03 May 2024 |
44.00 cr | Open |
|
Others
Creation Date: 17 Apr 2024 |
30.00 cr | Open |
Business Activity Principal business activity and turnover mix from MCA filings.
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | 98.17 |
Financial Ratios of Supriyalifescience Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.
Profitability, leverage and liquidity ratios require an active report plan.
Employees and EPFO Compliance at Supriyalifescience EPFO establishments, contributions, and headcount history. Full records unlock with your report.
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
GST Compliance of Supriyalifescience GST registrations and filing status by state. Full compliance detail unlocks with your report.
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
Credit Ratings, Litigation & Regulatory Alerts for Supriyalifescience Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
MSME Payment Delays by Supriyalifescience MSME supplier payment delays and filing history. Full amounts unlock with your report.
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
MCA Filings & Documents of Supriyalifescience Official MCA forms, returns, and filing index. Document access unlocks with your report.
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
Who is the owner of Supriyalifescience?
Who are the current board members and directors of Supriyalifescience?
What is CIN of Supriyalifescience?
When was Supriyalifescience incorporated?
What is the registered address of Supriyalifescience?
What is the current status of Supriyalifescience?
What is the contact number or email for Supriyalifescience?
What industry or business activity is Supriyalifescience associated with?
What is paid-up capital and authorised share capital of Supriyalifescience?
When did Supriyalifescience last file accounts and hold an AGM?
Where can I see charges and lenders for Supriyalifescience?
Have any directors left Supriyalifescience?
What is the turnover or revenue of Supriyalifescience?
What is the net worth of Supriyalifescience?
How can I get the financial details of Supriyalifescience?
What is the official website of Supriyalifescience?
Which company owns supriyalifescience.com?
Is Supriyalifescience registered with any stock exchange in India?
Supriyalifescience - is it listed or unlisted?
What is the ROC code of Supriyalifescience?
What is the company classification of Supriyalifescience?
Does Supriyalifescience have GST registrations on file?
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.